Literature DB >> 33074865

Thrombotic Risk of Rotor Speed Modulation Regimes of Contemporary Centrifugal Continuous-flow Left Ventricular Assist Devices.

Andrea Boraschi1,2, Silvia Bozzi1, Bente Thamsen3, Marcus Granegger3, Lena Wiegmann2, Federico Pappalardo4,5, Marvin J Slepian6,7, Vartan Kurtcuoglu2, Alberto Redaelli1, Diane De Zélicourt2, Filippo Consolo4.   

Abstract

Contemporary centrifugal continuous-flow left ventricular assist devices (LVADs) incorporate dynamic speed modulation algorithms. Hemocompatibility of these periodic unsteady pump operating conditions has been only partially explored. We evaluated whether speed modulation induces flow alterations associated with detrimental prothrombotic effects. For this aim, we evaluated the thrombogenic profile of the HeartWare ventricular assist device (HVAD) Lavare Cycle (LC) and HeartMate3 (HM3) artificial pulse (AP) via comprehensive numerical evaluation of (i) pump washout, (ii) stagnation zones, (iii) shear stress regimens, and (iv) modeling of platelet activation status via the platelet activity state (PAS) model. Data were compared between different simulated operating scenarios, including: (i) constant rotational speed and pump pressure head, used as reference; (ii) unsteady pump pressure head as induced by cardiac pulsatility; and (iii) unsteady rotor speed modulation of the LC (HVAD) and AP (HM3). Our results show that pump washout did not improve across the different simulated scenarios in neither the HVAD nor the HM3. The LC reduced but did not eliminate flow stagnation (-57%) and did not impact metrics of HVAD platelet activation (median PAS: +0.4%). The AP reduced HM3 flow stagnation by up to 91% but increased prothrombotic shear stress and simulated platelet activation (median PAS: +124%). Our study advances understanding of the pathogenesis of LVAD thrombosis, suggesting mechanistic implications of rotor speed modulation. Our data provide rationale criteria for the future design optimization of next generation LVADs to further reduce hemocompatibility-related adverse events.
Copyright © ASAIO 2020.

Entities:  

Year:  2021        PMID: 33074865     DOI: 10.1097/MAT.0000000000001297

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  3 in total

1.  A New Mathematical Numerical Model to Evaluate the Risk of Thrombosis in Three Clinical Ventricular Assist Devices.

Authors:  Yuan Li; Hongyu Wang; Yifeng Xi; Anqiang Sun; Xiaoyan Deng; Zengsheng Chen; Yubo Fan
Journal:  Bioengineering (Basel)       Date:  2022-05-27

2.  Insights Into the Low Rate of In-Pump Thrombosis With the HeartMate 3: Does the Artificial Pulse Improve Washout?

Authors:  Peng Fang; Jianjun Du; Andrea Boraschi; Silvia Bozzi; Alberto Redaelli; Marianne Schmid Daners; Vartan Kurtcuoglu; Filippo Consolo; Diane de Zélicourt
Journal:  Front Cardiovasc Med       Date:  2022-03-11

3.  An Accelerated Thrombosis Model for Computational Fluid Dynamics Simulations in Rotary Blood Pumps.

Authors:  Christopher Blum; Sascha Groß-Hardt; Ulrich Steinseifer; Michael Neidlin
Journal:  Cardiovasc Eng Technol       Date:  2022-01-14       Impact factor: 2.305

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.